通过分子动力学和增强的采样模拟,对14-3-3η/帕金因子相互作用的联体介导调节进行机械洞察
Gourav Chakraborty1, Upasana Deka1, Niladri Patra1
1Department of Chemistry and Chemical Biology, Indian Institute of Technology (ISM) Dhanbad, Dhanbad 826004, India.
The journal of physical chemistry. B
|July 7, 2025
概括
这项研究确定了潜在的候选药物,Lig-2和Lig-4,可以破坏14-3-3η/帕金森相互作用,为帕金森症提供了新的治疗策略.
科学领域:
- 计算化学和结构生物学
- 神经科学和分子药理学.
背景情况:
- 帕金森病 (PD) 涉及蛋白质功能障碍,包括14-3-3η/帕金森综合体.
- 这种复合物使帕金激素失活,导致氧化应激和神经元死亡.
研究的目的:
- 用计算方法研究14-3-3η/帕金斯复杂化机制.
- 为了确定针对14-3-3η/帕金相互作用的小分子抑制剂,用于潜在的PD治疗.
主要方法:
- 经典分子动力学 (MD) 模拟和增强的采样协议.
- 虚拟选超过446,000个小分子,然后进行对接和ADMET分析.
- 分子力学一般化天生的表面积 (MM/GBSA) 和简化化学自由能扰乱 (SAFEP) 具有约束力的自由能估计.
主要成果:
- 在14-3-3η/帕金复合体中发现了一个正经口袋.
- 列出了五种候选药物,其中Lig-2和Lig-4显示出显著的潜力.
- 发现Lig-2和Lig-4削弱了蛋白质与蛋白质的相互作用,改变了蛋白质的动态.
结论:
- Lig-2和Lig-4作为14-3-3η/帕金综合体的正经抑制剂具有前景.
- 这些抑制剂可能通过调节蛋白相互作用来为帕金森病提供一种新的治疗方法.
相关概念视频
Ligand Binding Sites
13.4K
Proteins are dynamic macromolecules that carry out a wide variety of essential processes; however, the activities of most proteins depend on their interactions with other molecules or ions, known as ligands.
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
Protein-ligand interactions are quite specific; even though numerous potential ligands surround a cellular protein at any given time, only a particular ligand can bind to that protein. Moreover, a ligand binds only to a dedicated area on the surface of the protein, known as the...
13.4K
Ligand Binding and Linkage
4.9K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.9K
The Equilibrium Binding Constant and Binding Strength
13.7K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
13.7K
Covalently Linked Protein Regulators
7.3K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
7.3K
Cooperative Allosteric Transitions
2.4K
2.4K


